Cargando…

Effect of the ati Gene Deletion on the Pathogenicity and Immunogenicity of the Vaccinia Virus

Among the nonvirion proteins of the vaccinia virus (VACV), a 94-kDa long protein is most abundantly present; the protein is a truncated form of the 150-kDa A-type inclusion (ATI) protein of the cowpox virus encoded by the ati gene. This VACV protein does not form intracellular ATIs, being as it is a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yakubitskiy, S. N., Sergeev, A. A., Titova, K. A., Shulgina, I. S., Starostina, E. V., Borgoyakova, M. B., Karpenko, L. I., Shchelkunov, S. N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	A.I. Gordeyev 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10615193/ https://www.ncbi.nlm.nih.gov/pubmed/37908769 http://dx.doi.org/10.32607/actanaturae.17872

Ejemplares similares

Enhancing the Immunogenicity of Vaccinia Virus
por: Shchelkunov, Sergei N., et al.
Publicado: (2022)

Adaptive Immune Response to Vaccinia Virus LIVP Infection of BALB/c Mice and Protection against Lethal Reinfection with Cowpox Virus
por: Shchelkunov, Sergei N., et al.
Publicado: (2021)

Comparison of the Effectiveness of Transepidemal and Intradermal Immunization of Mice with the Vacinia Virus
por: Shchelkunov, S. N., et al.
Publicado: (2022)

Enhancing the Protective Immune Response to Administration of a LIVP-GFP Live Attenuated Vaccinia Virus to Mice
por: Shchelkunov, Sergei N., et al.
Publicado: (2021)

Attenuation of Vaccinia Virus
por: Yakubitskiy, S. N., et al.
Publicado: (2015)

Effect of the Route of Administration of the Vaccinia Virus Strain LIVP to Mice on Its Virulence and Immunogenicity
por: Shchelkunov, Sergei N., et al.
Publicado: (2020)

Genes that Control Vaccinia Virus Immunogenicity
por: Shchelkunov, S. N., et al.
Publicado: (2020)

The Influence of an Elevated Production of Extracellular Enveloped Virions of the Vaccinia Virus on Its Properties in Infected Mice
por: Shchelkunov, S. N., et al.
Publicado: (2020)

Smallpox vaccination in a mouse model
por: Shchelkunov, S.N., et al.
Publicado: (2023)

Construction and Immunogenicity of Modified mRNA-Vaccine Variants Encoding Influenza Virus Antigens
por: Starostina, Ekaterina V., et al.
Publicado: (2021)

Increased attenuation but decreased immunogenicity by deletion of multiple vaccinia virus immunomodulators
por: Sumner, Rebecca P., et al.
Publicado: (2016)

Мутации в гене A34R, приводящие к увеличению иммуногенности вируса осповакцины
por: Shchelkunov, S.N., et al.
Publicado: (2021)

Immunogenicity of the DNA/Protein Combined Vaccine against COVID-19
por: Borgoyakova, M. B., et al.
Publicado: (2023)

In silico Designed Ebola Virus T-Cell Multi-Epitope DNA Vaccine Constructions Are Immunogenic in Mice
por: Bazhan, Sergei I., et al.
Publicado: (2019)

Effect of the Deletion of Genes Encoding Proteins of the Extracellular Virion Form of Vaccinia Virus on Vaccine Immunogenicity and Protective Effectiveness in the Mouse Model
por: Meseda, Clement A., et al.
Publicado: (2013)

Deletion of Vaccinia Virus A40R Gene Improves the Immunogenicity of the HIV-1 Vaccine Candidate MVA-B
por: Pérez, Patricia, et al.
Publicado: (2020)

Species-specific identification of variola, monkeypox, cowpox, and vaccinia viruses by multiplex real-time PCR assay
por: Shchelkunov, Sergei N., et al.
Publicado: (2011)

Deletion of Fifteen Open Reading Frames from Modified Vaccinia Virus Ankara Fails to Improve Immunogenicity
por: Alharbi, Naif Khalaf, et al.
Publicado: (2015)

Bayesian Phylogeography and Pathogenic Characterization of Smallpox Based on HA, ATI, and CrmB Genes
por: Adam, Dillon C, et al.
Publicado: (2018)

Immunogenic Properties of the DNA Construct Encoding the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein
por: Borgoyakova, M. B., et al.
Publicado: (2021)

Deletion of immunomodulator C6 from vaccinia virus strain Western Reserve enhances virus immunogenicity and vaccine efficacy
por: Sumner, Rebecca P., et al.
Publicado: (2013)

Are Hamsters a Suitable Model for Evaluating the Immunogenicity of RBD-Based Anti-COVID-19 Subunit Vaccines?
por: Merkuleva, Iuliia A., et al.
Publicado: (2022)

Effect of Serial Passage on the Pathogenicity and Immunogenicity of Vaccinia Virus LC16m8 Strain
por: Eto, Akiko, et al.
Publicado: (2021)

Generation of an Attenuated Tiantan Vaccinia Virus Strain by Deletion of Multiple Genes
por: Li, Yiquan, et al.
Publicado: (2017)

Difficult Airway Society guidelines for awake tracheal intubation (ATI) in adults
por: Ahmad, I., et al.
Publicado: (2019)

Adjuvant-Induced Arthritis in Guinea Pigs
por: Taranov, O.S., et al.
Publicado: (2016)

Systemically administered DNA and fowlpox recombinants expressing four vaccinia virus genes although immunogenic do not protect mice against the highly pathogenic IHD-J vaccinia strain
por: Bissa, Massimiliano, et al.
Publicado: (2013)

Deletion of immunomodulatory genes as a novel approach to oncolytic vaccinia virus development
por: Ho, Tiffany Y., et al.
Publicado: (2021)

Wheat ATIs: Characteristics and Role in Human Disease
por: Geisslitz, Sabrina, et al.
Publicado: (2021)

Social uncertainty promotes signal complexity during approaches in wild chimpanzees (Pan troglodytes verus) and mangabeys (Cercocebus atys atys)
por: Grampp, Mathilde, et al.
Publicado: (2023)

Cationic Polymers for the Delivery of the Ebola DNA Vaccine Encoding Artificial T-Cell Immunogen
por: Karpenko, Larisa I., et al.
Publicado: (2020)

Primary structure of the membrane and nucleocapsid protein genes of feline infectious peritonitis virus and immunogenicity of recombinant vaccinia viruses in kittens
por: Vennema, Harry, et al.
Publicado: (1991)

Disabling complement regulatory activities of vaccinia virus complement control protein reduces vaccinia virus pathogenicity
por: Bernet, John, et al.
Publicado: (2011)

Genome stability of the vaccine strain VACΔ6
por: Maksyutov, R.A., et al.
Publicado: (2022)

Expression of DAI by an oncolytic vaccinia virus boosts the immunogenicity of the virus and enhances antitumor immunity
por: Hirvinen, Mari, et al.
Publicado: (2016)

QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics
por: O’Reilly, Paul G., et al.
Publicado: (2016)

A New Class of Uracil–DNA Glycosylase Inhibitors Active against Human and Vaccinia Virus Enzyme
por: Grin, Inga R., et al.
Publicado: (2021)

Deletion of the Vaccinia Virus Gene A46R, Encoding for an Inhibitor of TLR Signalling, Is an Effective Approach to Enhance the Immunogenicity in Mice of the HIV/AIDS Vaccine Candidate NYVAC-C
por: Perdiguero, Beatriz, et al.
Publicado: (2013)

Assessment of Immunogenicity and Efficacy of a Zika Vaccine Using Modified Vaccinia Ankara Virus as Carriers
por: López-Camacho, César, et al.
Publicado: (2019)

Oncolytic efficacy of thymidine kinase-deleted vaccinia virus strain Guang9
por: Deng, Lili, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4sd0vmmpe6dflfem8k46oshfi2